Table 3.
Target Gene | Lobular Hyperplasias vs. Malignant Tumors | Benign Tumors vs. Malignant Tumors |
---|---|---|
BRCA1 | - | - |
BRCA2 | - | - |
FOXO3 | ↑ ** | ↑ *** |
GATA4 | - | - |
HER2 | ↑ *** | ↑ *** |
HMGA1 | ↑ * | - |
HMGA2 | - | - |
HMGB1 | ↑ *** | ↑ * |
MAPK1 | - | - |
MAPK3 | ↑ ** | ↑ *** |
MCL1 | ↑ *** | ↑ *** |
MYC | - | - |
PFDN5 | ↑ ** | ↑ *** |
PIK3CA | ↑ * | ↑ ** |
PTEN | - | ↑ ** |
TP53 | ↑ * | ↑ * |
Results are classified as significant (* p < 0.05), very significant (** p < 0.01), and extremely significant (*** p < 0.001). Cells with hyphen (-) revealed no significant differences.